INDV FY 2022 Earnings — Indivior Pharmaceuticals Inc Revenue & Financial Results | Market Cap Arena

INDVIndivior Pharmaceuticals Inc

$4B

FY 2022 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$901M+13.9% YoY

Gross Profit

$750M83.2% margin

Operating Income

-$81M-9.0% margin

Net Income

-$44M-4.9% margin

EPS (Diluted)

$-0.37

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$9M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$1.8B

Total Liabilities

$1.7B

Stockholders' Equity

$51M

Cash & Equivalents

$778M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$901M	$791M	+13.9%
Gross Profit	$750M	$664M	+13.0%
Operating Income	-$81M	$213M	-138.0%
Net Income	-$44M	$205M	-121.5%